GustavoVelasquezMDMPH

PubMed

• Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
  Velasquez, G., Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Ekaterina V Kurbatova, William C Whitworth, Erin Sizemore, Kia Bryant, Wendy Carr,...> ;Clinical Infectious Diseases. 2024 Mar 11
• Standards for clinical trials for treating TB.
  P du Cros, J Greig, J-W C Alffenaar, G B Cross, C Cousins, C Berry, U Khan, P P J Phillips, G E Velásquez, J Furin, M Spigelman, J T Denholm, S S Thi, S Tiberi, G K L ...> ;The International Journal of Tuberculosis and Lung Disease. 2023 Dec 1
• Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-coun...
  Patil, S., Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M...> ;Trials. 2023 Nov 30
• 3 citations
  Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
  Michael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, Alyssa Bercasio, Anurag Bhargava, Madhavi Bhargava, Amy Bloom, Adithya Cattamanchi, Richard Chaisson, D...> ;Lancet. 2023 Oct 21
• 6 citations
  Recent advances in the treatment of tuberculosis.
  Motta, I., Boeree, M., Chesov, D., Dheda, K., Günther, G., Horsburgh, C., Kherabi, Y., Lange, C., Lienhardt, C., McIlleron, H., Paton, N., Stagg, H., Thwaites, G., Udw...> ;Clinical Microbiology and Infection. 2023 Jul 22
• Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru.
  Rifat S Rahman, Marco A Tovar, Jesús Peinado, J Santiago Palomino, Claudio Ramirez, Fernando Llanos-Zavalaga, Ernesto Peralta, Gissela Valderrama, Lourdes B Ramos Cord...> ;Open Forum Infectious Diseases. 2023 Jul 1
• Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis.
  Gustavo E Velásquez, Payam Nahid> ;American Journal of Respiratory and Critical Care Medicine. 2023 Apr 1
• 1 citations
  Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru.
  Stephanie Law, Marco A Tovar, Molly F Franke, Roger Calderon, Santiago Palomino, Gissella Valderrama, Fernando Llanos, Gustavo E Velásquez, Carole D Mitnick, Leonid Lecca> ;BMC Infectious Diseases. 2023 Feb 2
• 4 citations
  Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review.
  Tulip A Jhaveri, Celia Fung, Allison N LaHood, Andrew Lindeborg, Chengbo Zeng, Rifat Rahman, Paul A Bain, Gustavo E Velásquez, Carole D Mitnick> ;Journal of Clinical Medicine. 2022 Sep 26
• 2 citations
  Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
  Roger I Calderón, Tulip A Jhaveri, Marco A Tovar, J Santiago Palomino, Nadia N Barreda, Oswaldo M Sanabria, Jesús Peinado, Claudio Ramirez, L Fernando Llanos Zavalaga,...> ;Microbiology Spectrum. 2022 Aug 31
• 16 citations
  Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
  Lorenzo Guglielmetti, Elisa Ardizzoni, M. Atger, Elisabeth Baudin, Elmira A. Berikova, Maryline Bonnet, E. Chang, S. Cloez, Julia Coit, Vivian Cox, B. C. de Jong, C. D...> ;Trials. 2021 Sep 25
• 2 citations
  Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts.
  Scott Dryden-Peterson, Gustavo E Velásquez, Thomas J Stopka, Sonya Davey, Rajesh T Gandhi, Shahin Lockman, Bisola O Ojikutu> ;JAMA Health Forum. 2021 Sep 1
• Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.
  Marco A. Tovar, Jesus Peinado, Santiago Palomino, Fernando Llanos, Claudio A. Ramirez, Gisella Valderrama, Roger Calderon, Roger B Williams, Gustavo E. Velásquez, Caro...> ;Clinical Infectious Diseases. 2021 Apr 21
• 32 citations
  Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic.
  Scott Dryden-Peterson, Gustavo E. Velásquez, Thomas J. Stopka, Sonya Davey, Shahin Lockman, Bisola O. Ojikutu> ;JAMA Network Open. 2021 Feb 1
• 5 citations
  SARS-CoV-2 Testing Disparities in Massachusetts
  Scott Dryden-Peterson, Gustavo E. Velásquez, Thomas J. Stopka, Sonya Davey, Shahin Lockman, Bisola O. Ojikutu> ;Medrxiv. 2020 Nov 4
• 28 citations
  Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series.
  Jeffrey C Pearson, Brandon Dionne, Aaron Richterman, Samuel J. Vidal, Zoe Weiss, Gustavo E. Velásquez, Francisco M. Marty, Paul E. Sax, Sigal Yawetz> ;Open Forum Infectious Diseases. 2020 Sep 9
• 5 citations
  Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report.
  Rifat Rahman, Leela Davies, Amir M. Mohareb, Paula M Peçanha-Pietrobom, Nirav J. Patel, Isaac H. Solomon, David Meredith, Harrison Tsai, Jeffrey P. Guenette, Shamik Bh...> ;Open Forum Infectious Diseases. 2020 Apr 1
• 11 citations
  The fourth national anti-tuberculosis drug resistance survey in Peru.
  Neyda Quispe, Luis Asencios, Cristian Obregon, Gustavo E. Velásquez, Carole D. Mitnick, Michael M Lindeborg, Hector O. Jave, Lely Solari> ;The International Journal of Tuberculosis and Lung Disease. 2020 Feb 1
• 1 citations
  Quantitative assessment of the activity of antituberculosis drugs and regimens.
  Maxwell Chirehwa, Gustavo E. Velásquez, Tawanda Gumbo, Helen McIlleron> ;Expert Review of Anti-Infective Therapy. 2019 May 30
• Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
  Gustavo E. Velásquez, Meredith B Brooks, Julia Coit, Epifanio Sánchez Garavito, Roger Calderon, Judith Jimenez, Karen Tintaya, Charles A. Peloquin, Elna Osso, Leonid L...> ;American Journal of Respiratory and Critical Care Medicine. 2019 May 1
• 4 citations
  Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group.
  Gustavo E. Velásquez, Moises A. Huaman, Kimberly R. Powell, Susan E. Cohn, Shobha Swaminathan, Martine Outlaw, Gail Schulte, Quinteka McNeil, Judith S. Currier, Carlos...> ;Open Forum Infectious Diseases. 2019 Feb 11
• 47 citations
  Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
  Gustavo E. Velásquez, Meredith B Brooks, Julia Coit, Henry Pertinez, Dante Elmo Vargas Vasquez, Epifanio Sánchez Garavito, Roger Calderon, Judith Jimenez, Karen Tintay...> ;American Journal of Respiratory and Critical Care Medicine. 2018 Sep 1
• Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis.
  Gustavo E. Velásquez, Geraint Davies, Carole D. Mitnick> ;The International Journal of Tuberculosis and Lung Disease. 2018 May 1
• 2 citations
  A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept.
  Nina Jain, Jacob E. Lazarus, Inga-Marie Schaefer, Melanie Johncilla, Agoston T. Agoston, Anuj K. Dalal, Gustavo E. Velásquez> ;Journal of General Internal Medicine. 2018 Mar 12
• 1 citations
  Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
  Charles A. Peloquin, Gustavo E. Velásquez, Leonid Lecca, Roger Calderon, Julia Coit, M. Milstein, E. Osso, Judith Jimenez, Karen Tintaya, E. Sanchez Garavito, D. Varga...> ;Antimicrobial Agents and Chemotherapy. 2017 Aug 24
• Join now to see all